Startup profile for PsiQuantum: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

PsiQuantum funding, valuation and investors

Photonic quantum-computing developer building large fault-tolerant systems.

Verified company research · funding, investors and latest developments

Keep track of PsiQuantum

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series E

$1B · September 10, 2025

Latest known valuation

$7B at the financing; not a current market price

Series E · September 10, 2025

Total disclosed equity funding

$1.4B

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

growth · Palo Alto, California, United States

Investors in latest funding

Lead: Funds and accounts managed by affiliates of BlackRock , Temasek , Baillie Gifford

Other: Entities administered by Macquarie Capital , Ribbit Capital , NVentures , Adage Capital Management , Qatar Investment Authority , Type One Ventures , Counterpoint Global (Morgan Stanley) , 1789 Capital , S Ventures , Blackbird , Third Point , T. Rowe Price

Sources: latest funding · psiquantum.com Last verified: 2026-10-26

Overview

PsiQuantum is developing quantum computers based on photonic chips and semiconductor manufacturing. Its strategy targets a fault-tolerant machine rather than a small general-purpose processor sold as a finished product today. The company announced a $450 million Series D in July 2021 and a $1 billion Series E at a $7 billion valuation in September 2025.

The financing history below contains selected company-disclosed rounds, not an assertion that every earlier transaction is captured. Government support, research contracts and construction commitments must be tracked separately from private equity.

The commercial questions are whether optical losses, component quality, packaging and error-correction overhead can be controlled at system scale, and whether useful workloads justify the complete operating cost.

Why PsiQuantum is interesting

Its $1 billion Series E brought asset managers, sovereign capital and NVIDIA into a capital-intensive bet on photonic manufacturing and large-scale systems.

Funding history (newest first)

Series E

2025-09-10 $1B Valuation: $7B at the financing; not a current market price
  • Funds and accounts managed by affiliates of BlackRock (lead)
  • Temasek (lead)
  • Baillie Gifford (lead)
  • Entities administered by Macquarie Capital (participant)
  • Ribbit Capital (participant)
  • NVentures (participant)
  • Adage Capital Management (participant)
  • Qatar Investment Authority (participant)
  • Type One Ventures (participant)
  • Counterpoint Global (Morgan Stanley) (participant)
  • 1789 Capital (participant)
  • S Ventures (participant)
  • Blackbird (participant)
  • Third Point (participant)
  • T. Rowe Price (participant)

Source: Read source · psiquantum.com

Series D

2021-07-27 $450M
  • Funds and accounts managed by BlackRock (lead)
  • Baillie Gifford (participant)
  • M12 (participant)
  • Blackbird Ventures (participant)
  • Temasek (participant)

Source: Read source · businesswire.com

Investors in our directory

Funds linked from PsiQuantum's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

  • Xanadu direct

    Also pursues photonic quantum computing, but its architecture and commercial roadmap differ.

  • Quandela direct

    Photonic quantum-computing systems and components.

  • QuEra alternative

    Neutral-atom approach to quantum computing; financing size alone does not compare technical performance.

Industries

Market / IPO context

Editorial / static context — not a live quote.

FAQs about PsiQuantum

Practical answers founders, operators, and investors typically search for.

The September 10, 2025 company announcement stated a $7 billion valuation. That is a financing-date valuation, not a continuously updated market value.
No. Equity rounds, secondary share sales, research contracts and packages containing government equity, grants or loans must be separated before calculating totals.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.